The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation

Experimental Neurology

Volumn 253, Issue , 2014, Pages 126-137

  Grabrucker, Stefanie ^a   Proepper, Christian ^a   Mangus, Katharina ^a   Eckert, Matti ^a   Chhabra, Resham ^a   Schmeisser, Michael J ^a   Boeckers, Tobias M ^a   Grabrucker, Andreas M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Autism; HnRNP; LRRTM1; Nuclear shuttling; PSD; SCZ; Shank3; Synapse; Synaptotagmin 1

Indexed keywords

LEUCINE RICH REPEAT TRANSMEMBRANE NEURONAL PROTEIN 1; MEMBRANE PROTEIN; PROTEIN PROSAP2; PROTEIN SHANK3; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL NUCLEUS; CELL TRANSPORT; CONTROLLED STUDY; DENDRITE; GENE MUTATION; GENETIC RISK; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; SCHIZOPHRENIA; SYNAPSE; SYNAPTONUCLEAR SHUTTLING;

AUTISM; HNRNP; LRRTM1; NUCLEAR SHUTTLING; PSD; SCZ; SHANK3; SYNAPSE; SYNAPTOTAGMIN 1;

ANIMALS; ARGININE; CELL NUCLEUS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MUTATION; NERVE TISSUE PROTEINS; NEURAL CELL ADHESION MOLECULES; NEURONS; RATS; SYNAPSES; TIME FACTORS;

EID: 84892546130     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.12.015     Document Type: Article

References (72)

1. Alberini C.M. Transcription factors in long-term memory and synaptic plasticity. Physiol. Rev. 2009, 89:121-145.
2. Andrews R.C. Unification of the findings in schizophrenia by reference to the effects of gestational zinc deficiency. Med. Hypotheses 1990, 31(2):141-153.
3. Böckers T.M., Segger-Junius M., Iglauer P., Bockmann J., Gundelfinger E.D., Kreutz M.R., Richter D., Kindler S., Kreienkamp H.J. Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3' untranslated region of Shank1 mRNA. Mol. Cell. Neurosci. 2004, 26(1):182-190.
4. Boeckers T.M., Bockmann J., Kreutz M.R., Gundelfinger E.D. ProSAP/Shank proteins-a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J. Neurochem. 2002, 81(5):903-910.
5. Boeckers T.M., Liedtke T., Spilker C., Dresbach T., Bockmann J., Kreutz M.R., Gundelfinger E.D. C-terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3. J. Neurochem. 2005, 92(3):519-524.
6. Cheung C., Yu K., Fung G., Leung M., Wong C., Li Q., Sham P., Chua S., McAlonan G. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS One 2010, 5:e12233.
7. Condra J.A., Neibergs H., Wei W., Brennan M.D. Evidence for two schizophrenia susceptibility genes on chromosome 22q13. Psychiatr. Genet. 2007, 17:292-298.
8. de Lacy N., King B.H. Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology. Annu. Rev. Clin. Psychol. 2013, 9:555-587.
9. DeLisi L.E., Shaw S.H., Crow T.J., Shields G., Smith A.B., Larach V.W., Wellman N., Loftus J., Nanthakumar B., Razi K., Stewart J., Comazzi M., Vita A., Heffner T., Sherrington R. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am. J. Psychiatry 2002, 159(5):803-812.
10. Dieterich D.C., Karpova A., Mikhaylova M., Zdobnova I., König I., Landwehr M., Kreutz M., Smalla K.H., Richter K., Landgraf P., Reissner C., Boeckers T.M., Zuschratter W., Spilker C., Seidenbecher C.I., Garner C.C., Gundelfinger E.D., Kreutz M.R. Caldendrin-Jacob: a protein liaison that couples NMDA receptor signalling to the nucleus. PLoS Biol. 2008, 6(2):e34.
11. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsäter H., Sponheim E., Goubran-Botros H., Delorme R., Chabane N., Mouren-Simeoni M.C., de Mas P., Bieth E., Rogé B., Héron D., Burglen L., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 2007, 39(1):25-27.
12. Flavell S.W., Greenberg M.E. Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 2008, 31:563-590.
13. Francks C., Maegawa S., Laurén J., Abrahams B.S., Velayos-Baeza A., Medland S.E., Colella S., Groszer M., McAuley E.Z., Caffrey T.M., Timmusk T., Pruunsild P., Koppel I., Lind P.A., Matsumoto-Itaba N., Nicod J., Xiong L., Joober R., Enard W., Krinsky B., et al. LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol. Psychiatry 2007, 12(12):1129-1139.
14. Gauthier J., Champagne N., Lafrenière R.G., Xiong L., Spiegelman D., Brustein E., Lapointe M., Peng H., Côté M., Noreau A., Hamdan F.F., Addington A.M., Rapoport J.L., Delisi L.E., Krebs M.O., Joober R., Fathalli F., Mouaffak F., Haghighi A.P., Néri C., et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(17):7863-7868.
15. Gill M., Vallada H., Collier D., Sham P., Holmans P., Murray R., McGuffin P., Nanko S., Owen M., Antonarakis S., Housman D., Kazazian H., Nestadt G., Pulver A.E., Straub R.E., MacLean C.J., Walsh D., Kendler K.S., DeLisi L., Polymeropoulos M., et al. A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am. J. Med. Genet. 1996, 67(1):40-45.
16. Gilmour G., Dix S., Fellini L., Gastambide F., Plath N., Steckler T., Talpos J., Tricklebank M. NMDA receptors, cognition and schizophrenia-testing the validity of the NMDA receptor hypofunction hypothesis. Neuropharmacology 2012, 62(3):1401-1412.
17. Grabrucker A., Vaida B., Bockmann J., Boeckers T.M. Synaptogenesis of hippocampal neurons in primary cell culture. Cell Tissue Res. 2009, 338(3):333-341.
18. Grabrucker A.M., Knight M.J., Proepper C., Bockmann J., Joubert M., Rowan M., Nienhaus G.U., Garner C.C., Bowie J.U., Kreutz M.R., Gundelfinger E.D., Boeckers T.M. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J. 2011, 30(3):569-581.
19. Grabrucker A.M., Schmeisser M.J., Schoen M., Boeckers T.M. Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol. 2011, 21(10):594-603.
20. Grabrucker S., Jannetti L., Eckert M., Gaub S., Chhabra R., Pfaender S., Mangus K., Reddy P.P., Rankovic V., Schmeisser M.J., Kreutz M.R., Ehret G., Boeckers T.M., Grabrucker A.M. Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders. Brain 2013, (in press).
21. Greenwood T.A., Light G.A., Swerdlow N.R., Radant A.D., Braff D.L. Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS One 2012, 7(1):e29630.
22. Harrison P.J., Eastwood S.L. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 2001, 11(5):508-519.
23. Hashimoto S., Boissel S., Zarhrate M., Rio M., Munnich A., Egly J.M., Colleaux L. MED23 mutation links intellectual disability to dysregulation of immediate early gene expression. Science 2011, 333(6046):1161-1163.
24. Heckers S., Rauch S.L., Goff D., Savage C.R., Schacter D.L., Fischman A.J., Alpert N.M. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1998, 1(4):318-323.
25. Inoue S., Imamura A., Okazaki Y., Yokota H., Arai M., Hayashi N., Furukawa A., Itokawa M., Oishi M. Synaptotagmin XI as a candidate gene for susceptibility to schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(3):332-340.
26. Ishikawa M., Mizukami K., Iwakiri M., Kamma H., Ikonomovic M.D., Dekosky S.T., Asada T. Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease. Neurosci. Res. 2004, 50(4):481-484.
27. Jiang Y.H., Ehlers M.D. Modeling autism by SHANK gene mutations in mice. Neuron 2013, 78(1):8-27.
28. Jordan B.A., Kreutz M.R. Nucleocytoplasmic protein shuttling: the direct route in synapse-to-nucleus signaling. Trends Neurosci. 2009, 32:392-401.
29. Jordan B.A., Fernholz B.D., Khatri L., Ziff E.B. Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons. Nat. Neurosci. 2007, 10(4):427-435.
30. Jorgensen T.H., Børglum A.D., Mors O., Wang A.G., Pinaud M., Flint T.J., Dahl H.A., Vang M., Kruse T.A., Ewald H. Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands. Am. J. Med. Genet. 2002, 114(2):245-252.
31. Kanai Y., Dohmae N., Hirokawa N. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 2004, 43(4):513-525.
32. Kantrowitz J.T., Javitt D.C. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?. Brain Res. Bull. 2010, 83:108-121.
33. Kantrowitz J., Javitt D.C. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Curr. Opin. Psychiatry 2012, 25(2):96-102.
34. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., Gos A., Nestadt G., Wolyniec P.S., Lasseter V.K., Eisen H., Childs B., Kazazian H.H., Kucherlapati R., Antonarakis S.E., Pulver A.E., Housman D.E. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. U. S. A. 1995, 95:7612-7616.
35. Karpova A., Bär J., Kreutz M.R. Long-distance signaling from synapse to nucleus via protein messengers. Adv. Exp. Med. Biol. 2012, 970:355-376.
36. Karpova A., Mikhaylova M., Bera S., Bär J., Reddy P.P., Behnisch T., Rankovic V., Spilker C., Bethge P., Sahin J., Kaushik R., Zuschratter W., Kähne T., Naumann M., Gundelfinger E.D., Kreutz M.R. Encoding and transducing the synaptic or extrasynaptic origin of NMDA receptor signals to the nucleus. Cell 2013, 152(5):1119-1133.
37. Kindler S., Wang H., Richter D., Tiedge H. RNA transport and local control of translation. Annu. Rev. Cell Dev. Biol. 2005, 21:223-245.
38. Kindler S., Dieterich D.C., Schütt J., Sahin J., Karpova A., Mikhaylova M., Schob C., Gundelfinger E.D., Kreienkamp H.J., Kreutz M.R. Dendritic mRNA targeting of Jacob and N-methyl-d-aspartate-induced nuclear translocation after calpain-mediated proteolysis. J. Biol. Chem. 2009, 284(37):25431-25440.
39. Krecic A.M., Swanson M.S. hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 1999, 11(3):363-371.
40. Kreienkamp H.J. Scaffolding proteins at the postsynaptic density: shank as the architectural framework. Handb. Exp. Pharmacol. 2008, 186:365-380.
41. Kristiansen L.V., Patel S.A., Haroutunian V., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 2010, 64(7):495-502.
42. Lai K.O., Zhao Y., Ch'ng T.H., Martin K.C. Importin-mediated retrograde transport of CREB2 from distal processes to the nucleus in neurons. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17175-17180.
43. Lennertz L., Wagner M., Wölwer W., Schuhmacher A., Frommann I., Berning J., Schulze-Rauschenbach S., Landsberg M.W., Steinbrecher A., Alexander M., Franke P.E., Pukrop R., Ruhrmann S., Bechdolf A., Gaebel W., Klosterkötter J., Häfner H., Maier W., Mössner R. A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur. Arch. Psychiatry Clin. Neurosci. 2012, 262(2):117-124.
44. Ludwig K.U., Mattheisen M., Mühleisen T.W., Roeske D., Schmäl C., Breuer R., Schulte-Körne G., Müller-Myhsok B., Nöthen M.M., Hoffmann P., Rietschel M., Cichon S. Supporting evidence for LRRTM1 imprinting effects in schizophrenia. Mol. Psychiatry 2009, 14(8):743-745.
45. Meffert M.K., Chang J.M., Wiltgen B.J., Fanselow M.S., Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat. Neurosci. 2003, 6:1072-1078.
46. Meyer U., Feldon J., Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr. Res. 2011, 69(5 Pt 2):26R-33R.
47. Mikenberg I., Widera D., Kaus A., Kaltschmidt B., Kaltschmidt C. Transcription factor NF-kappaB is transported to the nucleus via cytoplasmic dynein/dynactin motor complex in hippocampal neurons. PLoS One 2007, 2(7):e589.
48. Mizukami K., Ishikawa M., Iwakiri M., Ikonomovic M.D., Dekosky S.T., Kamma H., Asada T. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease. Neurosci. Lett. 2005, 386(2):111-115.
49. Moghaddam B., Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012, 37:4-15.
50. Mowry B.J., Holmans P.A., Pulver A.E., Gejman P.V., Riley B., Williams N.M., Laurent C., Schwab S.G., Wildenauer D.B., Bauché S., Owen M.J., Wormley B., Sanders A.R., Nestadt G., Liang K.Y., Duan J., Ribble R., Norton N., Soubigou S., Maier W., et al. Multicenter linkage study of schizophrenia loci on chromosome 22q. Mol. Psychiatry 2004, 9(8):784-795.
51. Mudge J., Miller N.A., Khrebtukova I., Lindquist I.E., May G.D., Huntley J.J., Luo S., Zhang L., van Velkinburgh J.C., Farmer A.D., Lewis S., Beavis W.D., Schilkey F.D., Virk S.M., Black C.F., Myers M.K., Mader L.C., Langley R.J., Utsey J.P., Kim R.W., et al. Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One 2008, 3(11):e3625.
52. Muslimov I.A., Patel M.V., Rose A., Tiedge H. Spatial code recognition in neuronal RNA targeting: role of RNA-hnRNP A2 interactions. J. Cell Biol. 2011, 194(3):441-457.
53. Nguyen Ba A.N., Pogoutse A., Provart N., Moses A.M. NLStradamus: a simple Hidden Markov Model for nuclear localization signal prediction. BMC Bioinforma. 2009, 10(1):202.
54. Nissim-Rafinia M., Chiba-Falek O., Sharon G., Boss A., Kerem B. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. Hum. Mol. Genet. 2000, 9(12):1771-1778.
55. Picchioni M.M., Murray R.M. Schizophrenia. BMJ 2007, 335(7610):91-95.
56. Proepper C., Johannsen S., Liebau S., Dahl J., Vaida B., et al. Abelson interacting protein 1 (Abi-1) is essential for dendrite morphogenesis and synapse formation. EMBO J. 2007, 26(5):1397-1409.
57. Proepper C., Steinestel K., Schmeisser M.J., Heinrich J., Steinestel J., Bockmann J., Liebau S., Boeckers T.M. Heterogeneous nuclear ribonucleoprotein k interacts with Abi-1 at postsynaptic sites and modulates dendritic spine morphology. PLoS One 2011, 6(11):e27045.
58. Roussignol G., Ango F., Romorini S., Tu J.C., Sala C., Worley P.F., Bockaert J., Fagni L. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J. Neurosci. 2005, 25(14):3560-3570.
59. Schmeisser M.J., Grabrucker A.M., Bockmann J., Boeckers T.M. Synaptic cross-talk between N-methyl-D-aspartate receptors and LAPSER1-beta-catenin at excitatory synapses. J. Biol. Chem. 2009, 284(42):29146-29157.
60. Schmeisser M.J., Ey E., Wegener S., Bockmann J., Stempel A.V., Kuebler A., Janssen A.L., Udvardi P.T., Shiban E., Spilker C., Balschun D., Skryabin B.V., St Dieck, Smalla K.H., Montag D., Leblond C.S., Faure P., Torquet N., Le Sourd A.M., Toro R., et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 2012, 486(7402):256-260.
61. Sokolov B.P., Tcherepanov A.A., Haroutunian V., Davis K.L. Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biol. Psychiatry 2000, 48(3):184-196.
62. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
63. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O'Neill F.A., Walsh D., Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 2002, 71:337-348.
64. Sun J., Kuo P.H., Riley B.P., Kendler K.S., Zhao Z. Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(7):1173-1181.
65. Takashima N., Odaka Y.S., Sakoori K., Akagi T., Hashikawa T., Morimura N., Yamada K., Aruga J. Impaired cognitive function and altered hippocampal synapse morphology in mice lacking Lrrtm1, a gene associated with schizophrenia. PLoS One 2011, 6(7):e22716.
66. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr. Res. 2009, 110(1-3):1-23.
67. Thompson K.R., Otis K.O., Chen D.Y., Zhao Y., O'Dell T.J., et al. Synapse to nucleus signaling during long-term synaptic plasticity; a role for the classical active nuclear import pathway. Neuron 2004, 44:997-1009.
68. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 2002, 42:165-179.
69. Vallada H., Curtis D., Sham P.C., Murray R.M., McGuffin P., Nanko S., Gill M., Owen M., Collier D.A. Chromosome 22 markers demonstrate transmission disequilibrium with schizophrenia. Psychiatr. Genet. 1995, 5(3):127-130.
70. van Os J., Kapur S. Schizophrenia. Lancet 2009, 374(9690):635-645.
71. Verpelli C., Dvoretskova E., Vicidomini C., Rossi F., Chiappalone M., Schoen M., Di Stefano B., Mantegazza R., Broccoli V., Böckers T.M., Dityatev A., Sala C. Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J. Biol. Chem. 2011, 286(40):34839-34850.
72. Zhao Z., Webb B.T., Jia P., Bigdeli T.B., Maher B.S., van den Oord E., Bergen S.E., Amdur R.L., O'Neill F.A., Walsh D., Thiselton D.L., Chen X., Pato C.N., Riley B.P., Kendler K.S., Fanous A.H. Association study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis. PLoS One 2013, 8(7):e67776.